GOALI: Developing New Hydrogen Isotope Exchange Strategies for Isotope Labelling of Pharmaceuticals

在化学系化学催化和化学合成项目的支持下，韦恩州立大学的罗龙博士和默克公司的李经纬博士正在开发药物氢同位素标记的新方法。通过使用非均相电化学和电化学，Luo团队寻求建立改进的化学方法，用于标记药物及其前体，无论是多个氢同位素原子还是在特定位点进行选择性标记。在多个位点的氢同位素掺入将改善用于在临床前和临床研究中检测和定量药物和药物代谢物的诊断信号。此外，位点选择性标记将为含氘药物的合成提供新的工具。该项目将为研究生和本科生提供独特的学习和培训经验，为未来多学科和跨学科研究的规范做好准备。根据GOALI奖，韦恩州立大学的罗龙博士和默克公司的李经纬博士将从事合成方法学研究，以开发药物氢同位素标记的新方法。该小组将侧重于：（1）开发非均相光催化剂，以利用其独特的催化剂-基底界面，相对于常规分子光催化剂实现额外的氢同位素交换位点（例如，使用金属硫族化物量子点光催化剂同时活化苄型和α-胺位点的努力）和（2）发展电化学方法，以实现具有相似化学反应性的位点之间的氢同位素交换位点选择性，例如α-氨基C-H键，利用电化学提供的时间分辨氧化还原环境来控制不同位点的反应动力学。该团队将致力于回答以下重要的科学问题：（1）在氢同位素交换反应期间，如何通过异质光催化剂-基底界面实现有效的氢原子转移？(2)如何通过调节电化学氧化还原环境来控制氢同位素交换反应的反应途径？该项目的影响将不仅限于药物的氢同位素标记领域，还可能为控制光催化和电化学反应的一般反应途径提供新的策略。该奖项反映了NSF的法定使命，并通过使用基金会的知识价值和更广泛的影响审查标准进行评估，被认为值得支持。

With the support of the Chemical Catalysis and Chemical Synthesis programs in the Division of Chemistry, Dr. Long Luo of Wayne State University and Dr. Jingwei Li of Merck & Co are developing new methods for hydrogen isotope labeling of pharmaceuticals. With the use of heterogeneous photocatalysis and electrochemistry, the Luo team seeks to establish improved chemical methods for labeling pharmaceuticals and their precursors with either multiple hydrogen isotope atoms or selective labeling at specific sites. Hydrogen isotope incorporation at multiple sites will improve the diagnostic signals for detecting and quantifying drugs and drug metabolites in preclinical and clinical studies. In addition, the site-selective labeling will provide new tools for synthesizing drugs containing deuterium. This integrated university/industry research program will provide unique learning and training experience for graduate and undergraduate students, preparing this “next generation workforce” for a future in which multi- and inter-disciplinary research is the norm.Under this GOALI award, Dr. Long Luo of Wayne State University and Dr. Jingwei Li of Merck & Co will engage in synthetic methodology research toward new approaches to hydrogen isotope labeling of pharmaceuticals. The team will focus on: (1) developing heterogeneous photocatalysts to enable additional hydrogen isotope exchange sites relative to the conventional molecular photocatalysts utilizing their unique catalyst-substrate interface (For example, efforts to simultaneously activate benzylic and α-amine sites using metal chalcogenide quantum dot photocatalysts) and (2) developing electrochemical methods to achieve the hydrogen isotope exchange site selectivity among sites with similar chemical reactivity such as α-amino C-H bonds, utilizing the time-resolved redox environment provided by electrochemistry to control the reaction kinetics at different sites. The team will work to answer the following important scientific questions: (1) how can one achieve efficient hydrogen atom transfer via the heterogenous photocatalyst-substrate interface during a hydrogen isotope exchange reaction? (2) how can one control the reaction pathways of hydrogen isotope exchange reactions by tuning the electrochemical redox environment? The impact of this project will not be limited to the field of hydrogen isotope labeling of pharmaceuticals but will likely also provide new strategies for controlling reaction pathways in general for photocatalytic and electrochemical reactions.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.